PUBLISHER: Market Glass, Inc. | PRODUCT CODE: 2143637
PUBLISHER: Market Glass, Inc. | PRODUCT CODE: 2143637
Global Breast Biopsy Devices Market to Reach US$4.8 Million by 2032
The global market for Breast Biopsy Devices estimated at US$3.4 Million in the year 2025, is expected to reach US$4.8 Million by 2032, growing at a CAGR of 4.9% over the analysis period 2025-2032. Vacuum-Assisted Biopsy Procedure, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$1.6 Million by the end of the analysis period. Growth in the Core Needle Biopsy Procedure segment is estimated at 3.8% CAGR over the analysis period.
The U.S. Market is Estimated at US$930.7 Thousand While China is Forecast to Grow at 8.6% CAGR
The Breast Biopsy Devices market in the U.S. is estimated at US$930.7 Thousand in the year 2025. China, the world's second largest economy, is forecast to reach a projected market size of US$1.0 Million by the year 2032 trailing a CAGR of 8.6% over the analysis period 2025-2032. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.2% and 4.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.1% CAGR.
Global Breast Biopsy Device Market - Key Trends and Drivers Summarized
Breast cancer remains a leading cause of cancer-related deaths among women worldwide. This underscores the critical need for effective screening tools that can accurately detect cancer early, improving patient outcomes and reducing mortality rates. Breast biopsy devices play a crucial role in diagnosing breast cancer and abnormalities, as accurate early detection can significantly reduce mortality rates. Market growth for these devices is driven by a rising incidence of breast cancer and advancements in imaging technology, such as mammography, MRI, and ultrasound. Image-guided biopsies now allow precise targeting of suspicious lesions, enhancing diagnostic accuracy while minimizing repeat procedures and patient discomfort. National screening programs have also increased awareness, leading to higher demand for biopsies.
Key trends include technological innovations such as vacuum-assisted biopsies and automated biopsy guns, which offer greater accuracy, less invasiveness, and improved patient comfort compared to traditional methods. Minimally invasive methods, such as vacuum-assisted needle biopsies, are gaining popularity due to reduced discomfort and scarring. Automated disposable biopsy devices help prevent infection, reduce operator fatigue, and increase efficiency. Integration with advanced imaging and AI technologies refines the biopsy process by identifying the best sites for tissue extraction, reducing unnecessary biopsies, and enhancing diagnostic efficiency.
Precision medicine is also shaping the biopsy market, as biomarker-driven insights from biopsy samples enable personalized treatment plans. AI helps tailor therapies based on individual genetic profiles and disease characteristics, providing clinicians with comprehensive analyses and actionable insights. This shift towards personalized and precision medicine is enhancing the biopsy's value beyond diagnosis, leading to more effective and individualized cancer interventions.
SCOPE OF STUDY:
The report analyzes the Breast Biopsy Devices market by the following Segments, and Geographic Regions/Countries:
Segments:
Procedure (Vacuum-Assisted Biopsy Procedure, Core Needle Biopsy Procedure, Fine Needle Aspiration Biopsy Procedure, Surgical Biopsy Procedure, Liquid Biopsy Procedure); Technology (Ultrasound-Guided Technology, Mammography / Stereotactic-Guided Technology, MRI-Guided Technology); End-Use (Hospitals End-Use, Ambulatory Surgery Centers End-Use, Specialized Breast Care Centers End-Use, Diagnostic Centers / Imaging Centers End-Use)
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
SELECT PLAYERS -
WHAT SETS THIS REPORT APART FROM OTHERS?
Grounded in Domain Expert Perspectives - Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.
Captures Early Market Signals - Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.
Draws From a Broad, Validated Intelligence Base - Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.
Connects Signals With Strategic Market Direction - Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.
Provides In-Depth Company Intelligence - Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.
Market Share Is Examined Where It Matters - A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, Market Glass reports extend market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.